İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metronidazolum - compresse rivestite con film - metronidazolum 250 mg, excipiens pro compresso obducto. - malattie infettive attraverso la digestione anaerobica batteri o protozoi - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metronidazolum - compresse rivestite con film - metronidazolum 500 mg, excipiens pro compresso obducto. - malattie infettive attraverso la digestione anaerobica batteri o protozoi - synthetika

İsviçre - İtalyanca - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - metronidazolum - ovula - metronidazolum 500 mg, excipiens pro asteraceae ha. - malattie infettive attraverso la digestione anaerobica batteri o protozoi - synthetika

Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

medac gesellschaft für klinische spezialpräparate mbh - carmustina - hodgkin disease; lymphoma, non-hodgkin - agenti antineoplastici - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).

İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

tillomed italia srl - carmustina - carmustina

Avrupa Birliği - İtalyanca - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - agenti antineoplastici - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

waymade bv - carmustina - carmustina

İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

eugia pharma (malta) limited - carmustina - carmustina

İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

medac gesellschaft fur klinische spezialpraparate mbh - tiotepa - tiotepa

İtalya - İtalyanca - AIFA (Agenzia Italiana del Farmaco)

janssen cilag s.p.a. - itraconazolo - itraconazolo